Psychopharmacology Maastricht
The psychopharmacology department at Maastricht University focuses on the cognitive, behavioral, and biological effects of various substances, ranging from pharmaceutical to recreational drugs.
Learn More
Mind Altering Conversations with Mauro Cavara, featuring Steven Fülle
Check out the FIRST episode of our podcast series, MIND ALTERING CONVERSATIONS! In this series, psychedelic science student Steven Fülle talks to Dr. Mauro Cavara about his research into psilocybin being used for pain management in fibromyalgia.
Watch it here!
Congratulations to the NEW Dr. Eline C. H. M. Haijen!
After successfully defending her PhD thesis entitled: “Exploring the Adult ADHD Treatment Landscape: From Current Practices to Psychedelic Microdosing and Novel Screening Approaches.” In her thesis, she looks at novel approaches of treating ADHD with LSD microdosing.
Watch the defense here!Congratulations to the NEW Dr. Elisabeth Prevete!
On successfully defending her PhD thesis ‘Mental Effects and Potential Therapeutic Use of Kratom/Mitragynine!’ This project was a joint venture between Maastricht University and Sapienza University of Rome. This is Elisabeth’s SECOND doctorate, she now holds an MD and a PhD! Congrats once again Elisbath on a great accomplishment!
Watch the defense here!
Meet our Department!
The scientists in our lab come from many countries and backgrounds, all with highly unique research abilities. Come meet the people that make up the Psychopharmacology Department.
Learn MoreParticipate in our studies!
We're always conducting research in our department and we're frequently looking for participants to be a part of science! If you're interested, look at the studies that we are currently conducting.
View All Studies
Our Scientists
Katharina Lege, MSc
Cannabinoids, Neuroimaging, Consciousness
Coming from a background of psychology and clinical neuroscience, I developed a strong interest in altered states of the mind as in mediation or yoga practices.
Zain Gangaram, MSc
My research is multifaceted and is based on an RDoC model for Reactive Aggression (RA).
Dr. Pablo Mallaroni
fMRI/MRS, Idiosyncracy, Psychedelics
I am Postdoctoral Researcher with the Psychopharmacology Unit of Maastricht University with a background in translational neuroscience.
Aedan O’Shea, MSc
I have a long standing interest in unravelling the therapeutic mechanisms of Psychedelics, and in this project I will investigate the effect of Psychedelic drug exposure in humans on miRNA’s transported in neuron-derived Extracellular Vesicles...
Dr. Natasha Mason
Neuroadaptations, Plasticity, Psychedelics
My research is driven by my desire to find effective treatments for psychiatric disorders, particularly anxiety, depression, and post-traumatic stress disorder.
Melissa Vazquez Ruiz, MSc
Cognition, alcohol, Psychedelics
My research investigates how psychoactive substances, such as psychedelics influence cognition and emotion in legal contexts.
Simon Neugebauer, MSc
Affective Bias, Plasticity, Psychedelics
I specifically investigate how psychedelics can be used to pharmacologically probe and treat a negative affect biotype, that characterizes many emotional disorders.
Max Kaiser , MSc
I investigate whether inaccessible memories can be recovered and made retrievable again using various forms of non-invasive stimulation.
Dr. Eline Haijen
ADHD, Microdosing, Psychedelics
I am a post doctoral researcher in the Psychopharmacology in Maastricht research group at the Department of Neuropsychology and Psychopharmacology at Maastricht University. I am from a little village close to Maastricht.
Psychedelic Research
Psilocybin induces acute and persisting alterations in immune status and the stress response in healthy volunteers
→
Microdosing psychedelics: More questions than answers? An overview and suggestions for future research
→
A single inhalation of vapor from dried toad secretion containing 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in a naturalistic setting is related to sustained enhancement of satisfaction with life
5-MeO-DMT, naturalistic, psychopathological
→
Visual hallucinations originating in the retinofugal pathway under clinical and psychedelic conditions
hallucinations, visual, Psychedelics, vision, retinofugal, tripping
→
Spontaneous and deliberate creative cognition during and after psilocybin exposure
Psilocybin, Cognition, creativity
→
Cannabis Research
Medicinal Δ9-tetrahydrocannabinol (dronabinol) impairs on-the-road driving performance of occasional and heavy cannabis users but is not detected in Standard Field Sobriety Tests
→
Get in Touch
We are always up for communicating with people that have interesting ideas or questions. If you want to contact our department, please reach out using this form below.